{"url_path":"/sec/phge/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1739174/0001213900-26-059587-index.html","accession_number":"0001213900-26-059587","cik":"0001739174","ticker":"PHGE","issuer_name":"BiomX Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1739174/0001213900-26-059587-index.html","primary_entity_key":"0001739174","primary_entity_name":"BiomX Inc."},"word_count":56,"has_tables":true,"body_markdown":"**Item 5. Other Information.**\n\n \n\nDuring the three months ended\nMarch 31, 2026, none of our directors or officers (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended)\nadopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each\nterm is defined in Item 408(a) of Regulation S-K."}